glp 1 medications mechanism of action Frontiers Glucagon-like peptide-1 - Wikipedia

Common adverse effects are predominantly gastrointestinal and typically emerge during dose escalation: Nausea (affecting 2050% of users initially) Vomiting and diarrhoea Constipation Abdominal pain and bloating Reduced appetite (therapeutic effect but may be excessive) Fatigue and headache Injection site reactions (redness, swelling or itching) These effects usually diminish over several weeks as the body adjusts

Although the hereditary factors cannot be modified, but a lot improvement can be brought about as far as the lifestyle and environmental factors are concerned

Results are not medical advice

Surgery can be performed by most general surgeons, although experience with the technique is likely to improve outcomes